Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Intrinsic Value
The intrinsic value of one Caliway Biopharmaceuticals Co Ltd stock under the Base Case scenario is 437.89 TWD. Compared to the current market price of 699 TWD, Caliway Biopharmaceuticals Co Ltd is Overvalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Caliway Biopharmaceuticals Co Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Caliway Biopharmaceuticals Co Ltd
Balance Sheet Decomposition
Caliway Biopharmaceuticals Co Ltd
Current Assets | 9.7B |
Cash & Short-Term Investments | 9.7B |
Receivables | 5.2m |
Other Current Assets | 32m |
Non-Current Assets | 64.5m |
PP&E | 61.3m |
Other Non-Current Assets | 3.1m |
Free Cash Flow Analysis
Caliway Biopharmaceuticals Co Ltd
TWD | |
Free Cash Flow | TWD |
Earnings Waterfall
Caliway Biopharmaceuticals Co Ltd
Revenue
|
44.4m
TWD
|
Cost of Revenue
|
-13.7m
TWD
|
Gross Profit
|
30.8m
TWD
|
Operating Expenses
|
-747.9m
TWD
|
Operating Income
|
-717.1m
TWD
|
Other Expenses
|
128.3m
TWD
|
Net Income
|
-588.8m
TWD
|
Profitability Score
Profitability Due Diligence
Caliway Biopharmaceuticals Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Caliway Biopharmaceuticals Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Caliway Biopharmaceuticals Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Caliway Biopharmaceuticals Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Caliway Biopharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for Caliway Biopharmaceuticals Co Ltd is 1 060.8 TWD with a low forecast of 1 050.4 TWD and a high forecast of 1 092 TWD.
Dividends
Current shareholder yield for Caliway Biopharmaceuticals Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Caliway Biopharmaceuticals Co Ltd stock under the Base Case scenario is 437.89 TWD.
Compared to the current market price of 699 TWD, Caliway Biopharmaceuticals Co Ltd is Overvalued by 37%.